Literature DB >> 18619087

Huntington's disease: a caring approach to the end of life.

Joseph Klager1, Ayana Duckett, Susan Sandler, Carol Moskowitz.   

Abstract

This article describes the challenges of end-of-life care encountered in a specialized long-term care program for people with Huntington's disease (HD). The Promoting Excellence in End-of-Life Care Huntington's Disease Workgroup defines the initiation of palliative care as the point at which independent living is no longer possible. Mobility and lifestyle accommodations for people in the nursing home setting with an early-onset disease are a major feature of this program. The primary end-of-life considerations are advance directives decision-making and anticipating end-stage care needs. Disease progression, denial, family conflict, and clinician blind-spots may impede the development of timely advance directives. The unpredictable and idiosyncratic nature of disease progression impacts decision making for end-of-life care settings and approaches: hospitalization, nursing home stay, and in-house hospice care are the available options. The Workgroup has delineated several priority areas for patient care in HD: autonomy; dignity; meaningful social interaction; communication; comfort; safety and order; spirituality; enjoyment, entertainment and well-being; nutrition; and functional competence. This review also includes a description of the program features in each of these areas.

Entities:  

Mesh:

Year:  2008        PMID: 18619087     DOI: 10.1891/1521-0987.9.2.75

Source DB:  PubMed          Journal:  Care Manag J        ISSN: 1938-9019


  7 in total

Review 1.  Therapy in Huntington's disease: where are we?

Authors:  Martha A Nance
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

2.  New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system).

Authors:  N E Carlozzi; N R Downing; M K McCormack; S G Schilling; J S Perlmutter; E A Hahn; J S Lai; S Frank; K A Quaid; J S Paulsen; D Cella; S M Goodnight; J A Miner; M A Nance
Journal:  Qual Life Res       Date:  2016-07-08       Impact factor: 4.147

3.  A new measure for end of life planning, preparation, and preferences in Huntington disease: HDQLIFE end of life planning.

Authors:  Noelle E Carlozzi; E A Hahn; S A Frank; J S Perlmutter; N D Downing; M K McCormack; S Barton; M A Nance; S G Schilling
Journal:  J Neurol       Date:  2017-11-15       Impact factor: 4.849

Review 4.  Palliative Care for Movement Disorders.

Authors:  Christina L Vaughan; Benzi M Kluger
Journal:  Curr Treat Options Neurol       Date:  2018-02-21       Impact factor: 3.598

Review 5.  Palliative Care in Huntington Disease: Personal Reflections and a Review of the Literature.

Authors:  Christopher G Tarolli; Amy M Chesire; Kevin M Biglan
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-04-11

6.  Gaining insight into the views of outpatients with Huntington's disease regarding their future and the way they deal with their poor prognosis: a qualitative study.

Authors:  Marina R Ekkel; Marja F I A Depla; Els M L Verschuur; Ruth B Veenhuizen; Cees M P M Hertogh; Bregje D Onwuteaka-Philipsen
Journal:  BMC Palliat Care       Date:  2021-01-12       Impact factor: 3.234

7.  Survival, Mortality, Causes and Places of Death in a European Huntington's Disease Prospective Cohort.

Authors:  Filipe Brogueira Rodrigues; Daisy Abreu; Joana Damásio; Nilza Goncalves; Leonor Correia-Guedes; Miguel Coelho; Joaquim J Ferreira
Journal:  Mov Disord Clin Pract       Date:  2017-05-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.